BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teleanu DM, Chircov C, Grumezescu AM, Teleanu RI. Neuronanomedicine: An Up-to-Date Overview. Pharmaceutics 2019;11:E101. [PMID: 30813646 DOI: 10.3390/pharmaceutics11030101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Chircov C, Grumezescu AM, Holban AM. Magnetic Particles for Advanced Molecular Diagnosis. Materials (Basel) 2019;12:E2158. [PMID: 31284393 DOI: 10.3390/ma12132158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
2 Valadão KMG, Luizeti BO, Yamaguchi MU, Issy AC, Bernuci MP. Nanotechnology in Improving the Treatment of Huntington’s Disease: a Systematic Review. Neurotox Res. [DOI: 10.1007/s12640-021-00468-1] [Reference Citation Analysis]
3 Gomez-Zepeda D, Taghi M, Scherrmann JM, Decleves X, Menet MC. ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas. Pharmaceutics 2019;12:E20. [PMID: 31878061 DOI: 10.3390/pharmaceutics12010020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
4 Rai M, Yadav A, Ingle AP, Reshetilov A, Blanco-prieto MJ, Feitosa CM. Neurodegenerative Diseases: The Real Problem and Nanobiotechnological Solutions. In: Rai M, Yadav A, editors. Nanobiotechnology in Neurodegenerative Diseases. Cham: Springer International Publishing; 2019. pp. 1-17. [DOI: 10.1007/978-3-030-30930-5_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 González-Fernández C, Díaz Baños FG, Esteban MÁ, Cuesta A. Functionalized Nanoplastics (NPs) Increase the Toxicity of Metals in Fish Cell Lines. Int J Mol Sci 2021;22:7141. [PMID: 34281191 DOI: 10.3390/ijms22137141] [Reference Citation Analysis]
6 Khalin I, Adarsh N, Schifferer M, Wehn A, Groschup B, Misgeld T, Klymchenko A, Plesnila N. Size-Selective Transfer of Lipid Nanoparticle-Based Drug Carriers Across the Blood Brain Barrier Via Vascular Occlusions Following Traumatic Brain Injury. Small 2022;:e2200302. [PMID: 35384294 DOI: 10.1002/smll.202200302] [Reference Citation Analysis]
7 Gadzhimagomedova Z, Polyakov V, Pankin I, Butova V, Kirsanova D, Soldatov M, Khodakova D, Goncharova A, Mukhanova E, Belanova A, Maksimov A, Soldatov A. BaGdF5 Nanophosphors Doped with Different Concentrations of Eu3+ for Application in X-ray Photodynamic Therapy. Int J Mol Sci 2021;22:13040. [PMID: 34884843 DOI: 10.3390/ijms222313040] [Reference Citation Analysis]
8 Jan Z, Mollazadeh S, Abnous K, Taghdisi SM, Danesh A, Ramezani M, Alibolandi M. Targeted Delivery Platforms for the Treatment of Multiple Sclerosis. Mol Pharm 2022. [PMID: 35501974 DOI: 10.1021/acs.molpharmaceut.1c00892] [Reference Citation Analysis]
9 Lungu II, Grumezescu AM, Volceanov A, Andronescu E. Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview. Molecules 2019;24:E3547. [PMID: 31574993 DOI: 10.3390/molecules24193547] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 11.7] [Reference Citation Analysis]
10 Sorokina SA, Shifrina ZB. Dendrimers as Antiamyloid Agents. Pharmaceutics 2022;14:760. [DOI: 10.3390/pharmaceutics14040760] [Reference Citation Analysis]
11 Muthukrishnan L. Nanonutraceuticals — Challenges and Novel Nano-based Carriers for Effective Delivery and Enhanced Bioavailability. Food Bioprocess Technol. [DOI: 10.1007/s11947-022-02807-2] [Reference Citation Analysis]
12 Durazzo A, Nazhand A, Lucarini M, Atanasov AG, Souto EB, Novellino E, Capasso R, Santini A. An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics. Int J Mol Sci 2020;21:E2285. [PMID: 32225036 DOI: 10.3390/ijms21072285] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
13 Teixeira MI, Lopes CM, Amaral MH, Costa PC. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Eur J Pharm Biopharm 2020;149:192-217. [PMID: 31982574 DOI: 10.1016/j.ejpb.2020.01.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
14 Parvez S, Kaushik M, Ali M, Alam MM, Ali J, Tabassum H, Kaushik P. Dodging blood brain barrier with "nano" warriors: Novel strategy against ischemic stroke. Theranostics 2022;12:689-719. [PMID: 34976208 DOI: 10.7150/thno.64806] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kessas K, Chouari Z, Ghzaiel I, Zarrouk A, Ksila M, Ghrairi T, El Midaoui A, Lizard G, Kharoubi O. Role of Bioactive Compounds in the Regulation of Mitochondrial Dysfunctions in Brain and Age-Related Neurodegenerative Diseases. Cells 2022;11:257. [DOI: 10.3390/cells11020257] [Reference Citation Analysis]
16 Pottoo FH, Javed MN, Rahman JU, Abu-Izneid T, Khan FA. Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme. Semin Cancer Biol 2021;69:391-8. [PMID: 32302695 DOI: 10.1016/j.semcancer.2020.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
17 Alshememry AK, Yang JJ, Armstrong EA, Yager JY, Unsworth LD. Bacteriophage carriers localize in the brain of a rat model of neonatal hypoxic-ischemic encephalopathy. Biotechnol J 2021;:e2100226. [PMID: 34882965 DOI: 10.1002/biot.202100226] [Reference Citation Analysis]
18 Villa I, Villa C, Crapanzano R, Secchi V, Tawfilas M, Trombetta E, Porretti L, Brambilla A, Campione M, Torrente Y, Vedda A, Monguzzi A. Functionalized Scintillating Nanotubes for Simultaneous Radio- and Photodynamic Therapy of Cancer. ACS Appl Mater Interfaces 2021;13:12997-3008. [PMID: 33719410 DOI: 10.1021/acsami.1c02504] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Giraldo S, Alea-Reyes ME, Limón D, González A, Duch M, Plaza JA, Ramos-López D, de Lapuente J, González-Campo A, Pérez-García L. π-Donor/π-Acceptor Interactions for the Encapsulation of Neurotransmitters on Functionalized Polysilicon-Based Microparticles. Pharmaceutics 2020;12:E724. [PMID: 32752258 DOI: 10.3390/pharmaceutics12080724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Cunha A, Prévot G, Mousli Y, Barthélémy P, Crauste-Manciet S, Dehay B, Desvergnes V. Synthesis and Intracellular Uptake of Rhodamine-Nucleolipid Conjugates into a Nanoemulsion Vehicle. ACS Omega 2020;5:5815-23. [PMID: 32226861 DOI: 10.1021/acsomega.9b03992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Teleanu RI, Chircov C, Grumezescu AM, Volceanov A, Teleanu DM. Antioxidant Therapies for Neuroprotection-A Review. J Clin Med 2019;8:E1659. [PMID: 31614572 DOI: 10.3390/jcm8101659] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
22 Rajitha B, Malla RR, Vadde R, Kasa P, Prasad GLV, Farran B, Kumari S, Pavitra E, Kamal MA, Raju GSR, Peela S, Nagaraju GP. Horizons of nanotechnology applications in female specific cancers. Semin Cancer Biol 2021;69:376-90. [PMID: 31301361 DOI: 10.1016/j.semcancer.2019.07.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]